Codex
Hold: probability-weighted value is ₹234 versus ₹226 (+3.4%), reward/risk asymmetry is 1.19x, and position size should stay capped at 1.0% until underwriting and demerger execution both confirm.
What's Next
The next 3-6 months have event flow, but only one true rerating lever: repeatable earnings quality from Care-led underwriting and clean execution milestones on demerger.
What the market is likely to watch most closely is simple: does Care stop dragging consolidated profitability, and do demerger milestones move on schedule without governance noise.
The Verdict
The setup is not a clean long today. Deleveraging and control clarity are real positives, but the edge is thin because valuation already discounts part of that repair while earnings conversion remains unstable.
Current Price (₹)
Probability-Weighted Value (₹)
▲ 3.4% Expected Return
Asymmetry (Reward/Risk)
Suggested Max Position (% NAV)
Conviction (10-point)
What the market may still be missing is that CAP removal plus promoter-backed recap can create a cleaner earnings path than current skepticism implies. The counterpoint is stronger today: that improvement is not yet visible in stable consolidated ROE, so mispricing is modest.
At current odds and path risk, this is a watchlist-to-small-position setup, not a high-conviction add.